| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10135-736-51 | 10135-736 | HUMAN PRESCRIPTION DRUG | Lidocaine Hydrochloride | Lidocaine Hydrochloride | SOLUTION | TOPICAL | 20220601 | N/A | ANDA | ANDA216250 | Marlex Pharmaceuticals, Inc. | LIDOCAINE HYDROCHLORIDE | 40 mg/mL | 1 BOTTLE in 1 CARTON (10135-736-51) / 50 mL in 1 BOTTLE |
| 70954-518-10 | 70954-518 | HUMAN PRESCRIPTION DRUG | Lidocaine Hydrochloride | Lidocaine Hydrochloride | SOLUTION | TOPICAL | 20220323 | N/A | ANDA | ANDA216250 | Novitium Pharma LLC | LIDOCAINE HYDROCHLORIDE | 40 mg/mL | 1 BOTTLE in 1 CARTON (70954-518-10) / 50 mL in 1 BOTTLE |